NZ625621A - Treatment for diabetes in patients inappropriate for metformin therapy - Google Patents
Treatment for diabetes in patients inappropriate for metformin therapyInfo
- Publication number
- NZ625621A NZ625621A NZ625621A NZ62562109A NZ625621A NZ 625621 A NZ625621 A NZ 625621A NZ 625621 A NZ625621 A NZ 625621A NZ 62562109 A NZ62562109 A NZ 62562109A NZ 625621 A NZ625621 A NZ 625621A
- Authority
- NZ
- New Zealand
- Prior art keywords
- patients
- dpp
- medicament
- inhibitor
- methyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8662008P | 2008-08-06 | 2008-08-06 | |
EP08161989 | 2008-08-07 | ||
US10591508P | 2008-10-16 | 2008-10-16 | |
EP08166827 | 2008-10-16 | ||
NZ60396109 | 2009-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ625621A true NZ625621A (en) | 2015-11-27 |
Family
ID=55405604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ625621A NZ625621A (en) | 2008-08-06 | 2009-08-05 | Treatment for diabetes in patients inappropriate for metformin therapy |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ625621A (en) |
-
2009
- 2009-08-05 NZ NZ625621A patent/NZ625621A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ590787A (en) | DPP-4 inhibitors for treating diabetes in patients showing contraindication against metformin therapy | |
NZ605207A (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
NZ625577A (en) | Therapeutic uses of pharmaceutical compositions | |
JP2018131450A5 (en) | ||
JP5906086B2 (en) | Purine derivatives for use in the treatment of FAB-related diseases | |
JP4643760B2 (en) | A pharmaceutical comprising a combination or combination of a DPP-IV inhibitor and another antidiabetic agent | |
JP2023011007A5 (en) | ||
TWI618537B (en) | Diabetes therapy | |
US10034877B2 (en) | Treatment for diabetes in patients inappropriate for metformin therapy | |
JP2016518438A5 (en) | ||
NZ593754A (en) | Dpp-iv inhibitors for treatment of diabetes in paediatric patients | |
NZ625621A (en) | Treatment for diabetes in patients inappropriate for metformin therapy | |
US11911388B2 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
EA041228B1 (en) | TREATMENT OF DIABETES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 AUG 2016 BY SPRUSON + FERGUSON Effective date: 20160329 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2017 BY DENNEMEYER + CO. Effective date: 20160722 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2018 BY DENNEMEYER + CO Effective date: 20170726 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2019 BY DENNEMEYER + CO Effective date: 20180802 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2020 BY DENNEMEYER + CO. Effective date: 20190719 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2021 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20200727 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2022 BY DENNEMEYER + CO. Effective date: 20210726 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2023 BY DENNEMEYER + CO. SARL. Effective date: 20220725 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 AUG 2024 BY DENNEMEYER + CO. SARL Effective date: 20230724 |